AI in Healthcare Research Internships

The University of Toronto’s Master of Science in Applied Computing Program (MScAC) is inviting industry partners and hospitals to participate in a unique opportunity to host computer science graduate students for 8-month applied research internships. 

MScAC students are trained in AI in healthcare and life sciences, and possess strong technical skills in machine learning, data science, computational biology/informatics, and software engineering, and are seeking real-world challenges in healthcare. Utilize MScAC expertise to solve complex technological challenges, pilot innovative ideas through rapid prototyping and proof of concept development, and build, test, and evaluate models using state-of-the-art tools, frameworks, and methods. The MScAC program has a partnership with Mitacs that can be leveraged to help subsidize internships for eligible partners. 

 Timeline:

Internships take place from May 2026 – December 2026. Project submission opens October 14th, 2025.

 Application Process:

If you are interested in participating and/or learning more, please email Daniele Chirico or the team.

BioSTL 10th Annual Global Health Innovation Summit

Are you developing solutions that improve healthcare access and outcomes in rural communities?

The Consulate General of Canada in Chicago is partnering with BioSTL on the Global Health Innovation Summit (October 6–8, 2026, St. Louis). Connect directly with healthcare buyers representing more than $550B in purchasing power. Selected companies will have the opportunity to:

• Pitch to 200+ healthcare decision-makers

• Participate in curated 1:1 meetings with health systems, payers, and providers

• Access a dedicated Rural Health Day focused on solutions for underserved communities

• Learn from experts on U.S. market entry and healthcare commercialization strategies

If your innovation addresses rural health access, virtual care, aging at home, care coordination, AI in healthcare, or underserved populations, this is an excellent opportunity to build partnerships and grow in the U.S. market.

Canadian Life Sciences Mission to Mexico

The Trade Commissioner Service (TCS) at the Embassy of Canada to Mexico, in collaboration with Health Emergency Readiness Canada (HERC) will support a Canadian business delegation to Mexico City, focused on the pharmaceuticals and biopharmaceutical sub-sectors.

Canada is well-positioned to collaborate with Mexico in areas where it has strong global expertise and capabilities in AI-enabled drug discovery, advanced therapeutics, and enabling technologies, biomanufacturing, and data-driven health innovation. 

Through a coordinated Team Canada presence, the delegation program will support participating Canadian companies in raising their profile in Mexico, building strategic partnerships, and exploring commercial, investment, and R&D collaboration opportunities with leading Mexican stakeholders.  

Who should apply:

Innovative Canadian life sciences companies in pharmaceuticals and biotechnology that are looking to explore business partnerships with Mexican companies and organizations.

The Embassy of Canada and HERC will host a dedicated program for the business delegation including: 

• a webinar on Mexico’s life sciences ecosystem and business environment  

• pre-arranged business-to-business (B2B) meetings with Mexican companies, investors, and institutions  

• curated networking opportunities, including a Canada-hosted networking reception 

• site visits to leading pharmaceutical and biopharmaceutical facilities and research institutions

• ongoing support from the Trade Commissioner Service throughout and after the mission  

Benefits of participating

• Gain insights and market intelligence

• Develop a first-hand understanding of the opportunities and challenges of doing business in foreign markets

• Meet key commercial entities, industry players, and potential buyers, investors and/or partners

• Meet academic or research entities

• Participate in networking events

• Participate in pre-organized business-to-business meetings

• Increase visibility of your product or service

• Receive on-the-ground assistance from the Trade Commissioner Service

Registration deadline is September 1, 2026.

Build your best team yet: Become an I.D.E.A.L. Bioscience Employer in 2026

In today’s job market, people want more than pay. They want flexible work arrangements, a culture of belonging, strong leadership and opportunities for growth and learning. These are some of the everyday practices recognized by BioTalent Canada’s I.D.E.A.L. Bioscience Employer Recognition Program.This program lets you confidently and credibly brand your workplace as more than just a job. It shows employees you provide careers where they want to grow and belong.

The deadline to apply is November 28, 2025.

Apply to the Merck Digital Sciences Studio

Applications are now open for our 2026 cohort!

The Merck Digital Sciences Studio (MDSS) is a nine-month accelerator that invests in and supports early-stage startups developing digitally enabled technologies for drug discovery, pre-clinical, and clinical development.

Selected startups gain direct access to Merck experts, personalized mentoring from Centech advisors, and a SAFE investment from the Merck Global Health Innovation Fund (GHI), in collaboration with regional partners The Venture Collective (United States) and CQDM (Canada). Through this collaborative approach, MDSS connects innovators, researchers, and industry leaders to accelerate breakthroughs in health technology.

Apply before November 28.

Industry-Based Internships in the Regenerative Medicine Sector

The SCN-Mitacs industry-based internship partnership aims to pair the brightest graduate students and postdoctoral fellows with RM-focused biotech companies that are moving innovative therapies and technologies into the marketplace. This internship partnership is offered through the Mitacs Accelerate program and will match candidates with Canadian companies to complete an eight-month internship. Successful candidates will gain exposure to and work experience in industry and develop fundamental technical and business skills by undertaking a stem cell and regenerative medicine-related project.

Fill this expression of interest by December 5.

StartUps in the 6ix 2025

StartUps in the 6ix is back for its 3rd rendition! Come out and join the digital health emerging leader and startup community for an exciting night of learning and connecting. We’ll have a fireside chat featuring Tomi Poutanen, CEO, Signal 1, moderated by Joshua Liu, CEO and Co-Founder of SeamlessMD, followed by a startup expo to feature digital health startups in the Ontario ecosystem!

RESI 2026

RESI Europe 2026 - March 23, 2026

Virtual Partnering - March 24 & 25, 30 & 31, 2026

RESI San Diego - June 22

Virtual Partnering - June 23 & 24, 29 & 30, 2026

OBIO® members can access exclusive discount codes by logging into the member portal.

RESI Boston - September 22-23

Virtual Partnering - September 25, 28-29, 2026

AI-driven Medicines (AIM)

The AI-driven Medicines (AIM) program aims to drive transformative research that leverages computational or digital-based methods and tools to address critical, real-world challenges in the discovery and development of accessible and affordable medicines. This initiative focuses on supporting the development of innovative methodologies and tools to accelerate the drug discovery and development pipeline, bridging the gap between advanced computational theory and practical therapeutic applications.

Application deadline is December 31, 2026.

Applications Open for ECBG Cohort 4

Applications are open for the 4th cohort of the Executive Corporate Board Governance (ECBG) program, an initiative led by Women in Bio Greater Montreal in collaboration with the Rotman School of Management.

Since 2022, ECBG has empowered over 75 life sciences leaders to strengthen their board readiness while advancing diversity, equity, and inclusion in governance.

Program highlights:

• 📅 Training: January–February 2027 (online)

• 📝 Recruitment: May–October 2026

• 🎓 Delivered with: Rotman School of Management

Whether you are an aspiring board member or an organization committed to strengthening governance, this is an opportunity to take action.

IPON Explained 2026

IPON Explained is designed to help innovators and ecosystem partners better understand the importance of intellectual property (IP) and how IPON can help Ontario innovators protect and grow what’s made-in-Ontario.

Fast Track Your Pharma Career at the University of Toronto Mississauga

Registration is open for the Pharma Challenges & Opportunities Certificate, a unique program designed by top pharma leaders and U of T faculty to close today’s critical skill gaps.

Starting this September, the fully online program runs one Thursday a month for 4 months. You’ll gain a 360° view of the pharma industry, from drug discovery to market access and product launch, while sharpening key skills in communication, negotiation, and collaboration.

Learn from 15+ industry experts and faculty, tackle real-world challenges, and gain the practical skills and knowledge that employers in pharma and life sciences value most.

Fee: $2000 +HST.

Insight to Innovation

Have You Identified an Unmet Need in Healthcare?

Many meaningful healthcare innovations begin with someone on the front lines recognizing that there has to be a better way.

The Medical Device Development Centre's (MDDC) Insight to Innovation (I2I) initiative encourages clinicians, nurses, technologists, researchers, engineers, scientists and other healthcare professionals to bring forward unmet healthcare needs they have identified firsthand in healthcare.

Whether you are exploring an early insight or already developing a potential solution, I2I provides mentorship, connections across the MedTech ecosystem, and recognition awards of up to $25,000 to help advance promising healthcare innovations.

MDDC does not take any intellectual property (IP) or equity, allowing applicants to retain full ownership while exploring and advancing promising healthcare innovations.

Silicon Valley Agentic and Enterprise AI Canadian Technology Accelerator 2026-27

Artificial intelligence (AI) is reshaping every industry and Silicon Valley remains the epicenter of innovation, investment, and adoption. This program provides Canadian AI companies with a direct pathway to scale into the United States (U.S.) market.

Led by the Consulate General of Canada in Palo Alto, this Canadian Technology Accelerator (CTA) is designed to help Canadian AI companies fast-track their U.S. growth through direct access to enterprise buyers, strategic investors, and world-class innovation partners.

The CTA is anchored around The AI Conference (September 29 to October 1 in San Francisco), a premier gathering shaping the future of artificial intelligence. You'll be in the room with the industry's most influential builders, buyers, and backers.

Spots are limited. Apply before July 15.

Enhancing Medical Capability in Austere Environments

IDEaS is launching a new contest – Enhancing medical capability in austere environments

This challenge is seeking innovative solutions to strengthen medical care in resource-constrained operational environments through two challenge streams:

·    Forward oxygen delivery: Portable, high-performance oxygen systems for forward deployment

·    Sustainable surgical capability: Solutions that help surgical teams operate longer with minimal resupply

Who can apply?

·    Academia

·    not-for-profit and for-profit organizations

·    provincial, territorial and municipal governments

Deadline to submit proposals: October 8, 2026, at 2:00 p.m. EDT

Ontario AI & Big Data Export Business Mission to Big Data & AI Paris 2026

Big Data & AI Paris is one of Europe’s leading events focused on artificial intelligence, data technologies, cloud computing, and enterprise digital transformation. Held annually in Paris, the event attracts more than 20,000 participants and over 350 exhibitors, including senior decision-makers from sectors such as finance, manufacturing, telecommunications, transportation, energy, retail, and government. The Ontario mission will include turn key exhibitor space within the Ontario pavilion, targeted B2B matchmaking, group briefings, and strategic networking activities designed to connect Ontario firms with European buyers, integrators, and innovation partners seeking advanced AI and data solutions.

The mission will be delivered in close collaboration with Ontario’s Trade and Investment Offices in Europe, the Trade Commissioner Service, and relevant industry associations.

Booths will be assigned on a first-come, first-served basis. Companies that complete payment first will have priority in selecting their booth location. Applications will be reviewed and approved as they are received, so it’s important that companies complete the registration by paying the fee promptly to secure their spot.

Cost: CAD $4,980.00.

For any questions, please reach out to Arman Giloyan or Mauricio Ospina.

Oncology Accelerator in France

The Trade Commissioner Service (TCS) Service is pleased to open applications for the Oncology Accelerator in France, taking place from September 21–24, 2026.

This mission is designed for innovative Canadian SMEs and scale-ups in oncology looking to accelerate their expansion into the French and European markets through meetings with leading pharmaceutical companies, research institutes, and key players in the French ecosystem.

More information about the program is available on this One Pager.

There will also be an information webinar on June 8 to present the program and answer questions.

 Applications are open until June 21.

Horizon Europe Health Virtual Matchmaking Event

Looking for partners for a Pillar 2 Horizon Europe proposal? We are bringing together researchers and innovators from Belgium, Canada, France, Luxembourg, and Switzerland to forge new partnerships towards the 2027 Horizon Europe Cluster 1 calls.

Event Format

Using the following registration form, participants will be asked to provide their basic contact information, a summary of their expertise and how they align with the calls for collaboration. This information will be used by the organizers to invite a select number of participants for the event.

All selected participants will receive access to B2Match where they can arrange bilateral meetings with potential collaborators. The platform will be available from September 21 to September 25, 2026. Invited participants will also have an opportunity to pitch their project ideas during a virtual pitch session on September 22 among other invited participants and other event attendees.

The event registration will close on September 7.

BIONATION 2026

BIONATION is where Canada’s biotechnology and life sciences leaders come together with policymakers, elected officials, and sector partners to have the conversations that matter most for the future of the sector. Hosted by BIOTECanada, Canada’s voice for biotechnology, BIONATION is a rare opportunity to connect directly with decision-makers and sector leaders at a pivotal moment for Canadian biotech.

Christina Yeh, Vice President, Programs & Strategic Partnerships, and Mary Argent-Katwala, Senior Director, Stakeholder Engagement at OBIO®, will be attending BIONATION.

BioPort Atlantic

BioPort Atlantic celebrates 25 years this September. It's both a celebration and a challenge - a chance to showcase how our sector is improving lives, driving economic progress, and shaping a more sustainable future. From cutting-edge research and digital health to clean technology and biomanufacturing, BioPort will explore why what we do truly matters: to people, to communities, and to the world.

Bibaswan Ghoshal, Senior Director of Technology Adoption at OBIO®, will take the stage at BioPort Atlantic in September! He'll be joining the panel on "Innovation in Life Sciences: Navigating Dual Use and Impact." 

AI in Hospitals: From Hype to Implementation

This conference is highly relevant to Ontario’s digital health community, bringing together leaders from hospitals, health systems, and government to address the practical challenges of implementing AI in clinical environments. With speakers from organizations such as Humber River Health, North York General Hospital, Unity Health, and Hamilton Health Sciences, the event focuses on topics that are top of mind for Ontario healthcare organizations - including AI governance, clinician adoption, data readiness, privacy, and scaling successful innovations across the health system.

Note: “super early bird” and “early bird” registration discounts available until July 10 and August 21, respectively)

Good Documentation Practices (GDP): A Hands-On Introduction

This 1-day Good Documentation Practices (GDP) workshop equips participants with the practical documentation and data integrity skills required to work confidently in a GMP-regulated environment. Grounded in harmonized GDP principles, this full-day workshop bridges the gap between regulatory knowledge and day-to-day documentation practice. Through a combination of targeted instruction and hands-on activities, participants learn to write compliant SOPs, review and correct batch records, and execute documentation in real time.

Learning Objectives

• Identify the key principles of GDP and their application

• Apply ALCOA+ principles to paper-based records and identify common data integrity violations

• Recognise and classify documentation error codes and apply GMP-compliant corrections

• Distinguish between the document types used in GMP/GDP settings (SOPs, batch records, logbooks, CoAs, deviations, and more)

• Understand the principles for drafting GMP-compliant documents

• Gain confidence in the execution and review of manufacturing batch records through practical exercises

Who Should Attend

Ideal for anyone working in or transitioning into a GMP/GDP-regulated environment, including biomanufacturing operators, QA/QC staff, and production supervisors. No prior documentation training is required, though basic familiarity with GMP concepts is an asset. This course complements CASTL’s GMP Readiness Accelerator workshop and is designed to stand alone for open-enrolment participants.

September 24 I Montreal - Register here

October 8 I Charlottetown - Register here

NextGreatBigIdeas Summit

The NextGreatBigIdeas Summit is an annual, national networking event for Canada’s Life Sciences community. Join leaders, innovators, disruptors, and investors from across Canada for two days of networking, and national community building. 

Dr. Maura Campbell, President and CEO of OBIO®, will be speaking at the event.

OMD Educates: Digital Health Conference

This two-day conference will convene Ontario’s clinical and digital health communities to explore how technology can help reduce administrative burden and improve care delivery. Attendees can expect hands-on EMR learning, expert insights, networking, and exposure to emerging tools including AI-enabled solutions.

Who should attend?

The Digital Health Conference is ideal for physicians, nurse practitioners, nurses, allied health professionals and administrative/clinic staff. This conference is also for health system decision makers to hear directly from front-line clinicians about what they want and what they need.

Early bird registration will be Friday, August 21, 2026.

SPARK Accelerator Program for Pediatric Medical Countermeasure and Health Security Innovations

The SPARK Accelerator Program for Pediatric Medical Countermeasure and Health Security Innovations is a six-month, virtual, no-cost, equity-free program designed to support startups and academic innovators developing pediatric medical countermeasures and health security technologies. The accelerator is operated by Children's National Hospital in partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA).

Participants receive tailored support in:

• Regulatory strategy

• Clinical development

• Intellectual property

• Reimbursement pathways

• Commercialization planning

The program is open to non-U.S. applicants, making it accessible to Canadian innovators.

Technologies of Interest

SPARK is seeking innovations that support pediatric populations and align with BARDA's mission to address public health and health security threats. Areas of interest include:

• Diagnostics

• Medical devices

• Digital health technologies

• Therapeutics

• Vaccines

• Enabling technologies for pediatric product development and evidence generation

Specific enabling technologies of interest include:

• Pediatric digital twins

• Organoids, organ-on-chip, and other microphysiological systems

• Pharmacokinetic/pharmacodynamic (PK/PD) pediatric dosing models

• Simulation platforms for pediatric clinical trial design and response forecasting

Interested clients are encouraged to attend the Information Session on August 12, 2026 to learn more about the program and application process.

Interested and eligible applicants are encouraged to reach out to Aude-Alexia Véronneau so their participation can be logged and factored into future follow up.

Applications close on September 10.

Ontario Defence Business Mission to BIO Japan 2026 and Outreach Korea

October 7-9, 2026, and October 12, 2026

The Government of Ontario is leading a Life Science Business Mission to BIO Japan (October 7-9, 2026) in Yokohama, Japan, and Outreach Mission to Korea (October 12, 2026) in Seoul, South Korea.

BIO Japan 2026

• BIO Japan 2026 comprises 3 co‑located exhibitions (BioJapan, Regenerative Medicine, and healthTECH) with Exhibition, Seminars, and Partnering Programs. Ontario life science Mission to Bio Japan 2026 will take place at Pacifico Yokohama from October 7th to 9th, with the Ontario Pavilion. Bio Japan is the world's oldest biotechnology exposition and is the cornerstone of biotechnology industry in Japan providing platform for innovation and collaboration in biotechnology. Bio Japan 2025 had 500+ exhibitors and 30,000 visitors. Please find additional details of BIO Japan 2026 on the event webpage (https://jcd-expo.jp/en/).

• Exhibiting at Bio Japan (Yokohama, Japan) provides biopharmaceutical, life sciences, regenerative medicine, digital health, imaging, and medical technology companies in Ontario with opportunity to meet with potential customers and sales/distribution partners in Japan, and around the world. BIO Japan mission provides an opportunity to introduce Ontario life sciences (medical and assistive devices, digital health, AI, robotic, sensor and security, healthcare entertainment and management technologies) and bio sciences (drug discovery, drug development, drug manufacturing) companies to Japanese healthcare providers (hospital, clinics, long term care facilities, senior home etc.) and bio science companies (drug manufacturers, universities and clinical researches) as well as sales and distribution partners, and unlocking new export markets in Japan and increasing exports for Ontario companies. 

• Interested mission members are welcome to join extension Outreach Mission organized in Seoul, South Korea after the visit to Japan. South Korea presents a significant market potential. South Korea is proximity with Japan, sharing similar business culture. Outreach program in Seoul will include a market briefing session and curated B2B meetings at the Canadian Embassy follow-up meetings or group visit to a large Korean corporation.

• Ontario’s Trade and Investment Offices in Tokyo and Seoul will support programming and in‑market activities.

Who should participate? 

Ontario companies, which are interested in Japanese and/or /Korean life science markets, can showcase their products, services, and technologies at BIO Japan, which is ideal for Ontario Companies across the life‑science ecosystem, including biotech and pharmaceutical companies seeking partnerships and licensing deals, medical device manufacturers exploring digital health, diagnostics and regenerative medicine, chemical and materials companies working on biotech applications in materials and enzymes, research institutes aiming to commercialize discoveries, startups looking for visibility and investment, investors scouting emerging technologies, government and regulatory bodies supporting industry development, and service providers such as CROs and CDMOs who work with companies throughout the R&D and commercialization pipeline. These groups attend because BIO Japan is Asia’s most concentrated hubs for partnering, technology scouting, and cross‑border collaboration.

For further info, please reach out to Stephen Ip at MEDJCT.

Canada’s Semiconductor Symposium 2026

The 20th century saw the development, rapid evolution and spread of semiconductor technology. Their size, weight, power efficiencies and reliability met critical needs of the post-war period. It was a profound economic unlock. Over two days, the Symposium will explore the state of the industry and market implications as Canada defines new economic and security relationships. The focus is squarely on building a stronger, more resilient nation.

Dr. Maura Campbell, President and CEO of OBIO®, will be in conversation with Jarrod Morley, Vice-President Espace Aero, Quebec’s Aerospace Innovation Zone.

BioFuture Conference

BioFuture participants reflect a broad spectrum of pioneering companies, investors, partners, visionaries, and key opinion leaders influencing the rapid changes in therapeutics and technology today.

Jack Lee, Senior Director and Parnian Tajbakhsh, Senior Manager, Capital Access at OBIO®, will be attending the conference.

OBIO® members can access exclusive discount codes for presenting companies and attendee registration by logging into the member portal.

Trade Mission to BIO-Europe 2026

The Ontario Government in partnership with the Ontario Trade and Investment Office in Munich Germany, the Canadian Consulate in Dusseldorf, Germany, invites you to join the Ontario Export Business Mission to BIO-Europe.

The objective of this mission is to assist Ontario life sciences/biotechnology companies identify and meet with potential partners, customers, and investors, individuals companies would not normally have the opportunity to meet. BIO-Europe is an international forum designed to promote business development between pharmaceutical, financial and biotechnology companies. The event is Europe's largest partnering conference serving the global biotech industry. It offers networking opportunities, workshop and panel participation, high-profile exhibitions and prearranged one-on-one meetings. The event draws more than 4,000 delegates from over 60 companies.

Invest Ontario will have a 400 square-foot pavilion co-located with Global Affairs Canada, British Columbia and Quebec. This will serve as a convenient meeting place for the Ontario companies.

Apply before July 3.

Texas Life Science Forum

Call for life science ventures to present at the forum are due by midnight on Friday, October 2.

The Texas Life Science Forum (TLSF) is one of the leading life sciences and health tech conferences in Texas, bringing together biotech, medtech, diagnostics, digital health companies, investors, academic institutions and industry leaders focused on commercializing healthcare innovations. The event is co-hosted by BioHouston and the Rice Alliance for Technology and Entrepreneurship. TLSF is particularly well suited for Canadian biotech, medtech and digital health companies that are actively fundraising, seeking U.S. partnerships, validating market interest, or planning entry into the Texas healthcare ecosystem. The investor-focused format and structured networking opportunities make it a strong platform for companies with near-term commercialization and expansion objectives.

Dates & Location

• Forum: November 10, 2026

• Investor Office Hours: November 11, 2026

Who Should Attend

• Life sciences companies seeking capital, customers or strategic partners

• Biotech, medtech, diagnostics and digital health startups

• Venture capital, angel and corporate investors

• Universities, research institutions and technology transfer offices

• Pharmaceutical, medical device and healthcare industry stakeholders

• Economic development and innovation ecosystem organizations

Why Attend

• Company pitch sessions featuring emerging life science ventures

• One-on-one meetings with investors through the Office Hours program

• Networking with U.S. investors, corporate partners and healthcare innovators

• Insights on commercialization, financing and scaling health technologies

• Exposure to the Texas and broader U.S. life sciences ecosystem

MEDICA/Compamed trade fair

MEDICA/Compamed trade fair is one of the world’s largest medical trade fairs and a leading platform for showcasing innovations in healthcare technologies, medical devices, and digital health solutions.

The Canadian Trade Commissioner Service (TCS) will support Canadian companies attending MEDICA/Compamed through the following activities: 

• Canada Pavilion: A central hub on the exhibit floor for Canadian participants to connect with European industry leaders. 

• Networking Reception: At the Canada Pavilion, celebrating Canada-Germany milestones. 

• B2B Matchmaking: together with German partners (associations, clusters) DDORF will offer a matchmaking activity. 

• Export Café: meet Trade Commissioner from Europe and learn about their markets 

To express your interest in joining the Canadian delegation, contact our Trade Commissioner in Germany, Silke Ditgen.

Registration deadline is September 15.